If you liked this article you might like

Biogen Rallies Despite Mixed Revenue Guidance
Biotech Investors 'Spooked' After Trump's Comments, JMP's King Says
'Mad Money Lightning Round: Schlumberger Is the Best of Breed
These Stocks Are Too Hot, in a Bad Way : Jim Cramer's 'Mad Money' Recap